|Bid||177.93 x 800|
|Ask||178.12 x 900|
|Day's Range||174.33 - 179.30|
|52 Week Range||105.48 - 196.12|
|Beta (5Y Monthly)||1.34|
|PE Ratio (TTM)||42.20|
|Earnings Date||Oct 25, 2021 - Oct 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||180.25|
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Good morning and thank you for joining Medpace's second-quarter 2021 earnings conference call. Also on the call today is our President and CEO, August Troendle; our CFO and COO of laboratory operations, Jesse Geiger; and our executive director of finance, Kevin Brady.
Medpace (MEDP) delivered earnings and revenue surprises of 8.16% and 2.62%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?